UPSC MainsMEDICAL-SCIENCE-PAPER-I20245 Marks
Q22.

Describe the role of platelets in haemostasis.

How to Approach

This question requires a detailed understanding of platelet physiology and their multifaceted role in haemostasis. The answer should be structured around the three main phases of haemostasis – primary, secondary, and tertiary – explaining how platelets contribute to each. Focus on platelet activation, adhesion, aggregation, and the coagulation cascade. Mention relevant factors and inhibitors. A concise and clear explanation of the mechanisms involved is crucial for a good score.

Model Answer

0 min read

Introduction

Haemostasis, the process of stopping bleeding, is a vital physiological mechanism essential for maintaining vascular integrity. It involves a complex interplay of vascular, platelet, and coagulation factors. Platelets, also known as thrombocytes, are small, anucleate cell fragments derived from megakaryocytes in the bone marrow. They play a central and dynamic role in all stages of haemostasis, initiating the process and contributing to clot formation and stabilization. Understanding their function is crucial for comprehending bleeding disorders and thrombotic diseases.

Platelet Function in Haemostasis

Platelet involvement in haemostasis can be broadly categorized into three phases: primary haemostasis, secondary haemostasis, and tertiary haemostasis (clot stabilization and fibrinolysis). Platelets are critical in all three.

1. Primary Haemostasis: Platelet Plug Formation

This is the initial response to vascular injury. It involves platelet adhesion, activation, and aggregation.

  • Adhesion: Upon vascular damage, subendothelial collagen is exposed. Platelets adhere to this collagen via von Willebrand factor (vWF), acting as a bridge. Platelet surface receptors, such as glycoprotein Ib/IX/V complex, bind to vWF.
  • Activation: Adhesion triggers platelet activation. Activated platelets undergo a conformational change, exposing receptors like GPIIb/IIIa. They release granules containing various substances, including ADP, thromboxane A2 (TXA2), and serotonin.
  • Aggregation: Released ADP and TXA2 further activate nearby platelets, leading to their aggregation. GPIIb/IIIa receptors on activated platelets bind to fibrinogen, forming bridges between platelets and creating a platelet plug.

2. Secondary Haemostasis: Coagulation Cascade

While primary haemostasis provides a temporary plug, secondary haemostasis reinforces it with fibrin formation. Platelets play a crucial role in this process by providing a surface for coagulation factor activation.

  • Platelet Factor 3 (PF3): Activated platelets express PF3, a phospholipid complex that serves as a catalytic surface for the coagulation cascade.
  • Coagulation Factor Binding: Coagulation factors bind to PF3, accelerating the formation of thrombin.
  • Thrombin Generation: Thrombin converts fibrinogen into fibrin, which stabilizes the platelet plug.

3. Tertiary Haemostasis: Clot Stabilization and Fibrinolysis

This phase involves clot retraction and eventual breakdown of the clot.

  • Clot Retraction: Platelets contain contractile proteins (actin and myosin) that cause the clot to retract, bringing the wound edges closer together.
  • Fibrinolysis: Platelets also contribute to fibrinolysis by releasing plasminogen activators, initiating the breakdown of the fibrin clot.

Regulation of Platelet Function

Platelet function is tightly regulated to prevent both excessive bleeding and thrombosis.

  • Prostaglandin I2 (PGI2) & Nitric Oxide (NO): Released by endothelial cells, these substances inhibit platelet activation and aggregation.
  • Adenosine Diphosphate (ADP) Receptors: Blocking these receptors (e.g., with clopidogrel) reduces platelet aggregation.
  • Thromboxane A2 (TXA2) Synthesis Inhibitors: Aspirin inhibits TXA2 synthesis, reducing platelet activation.
Phase of Haemostasis Platelet Role
Primary Adhesion, Activation, Aggregation, Plug Formation
Secondary Provides surface for coagulation cascade (PF3), Thrombin generation
Tertiary Clot Retraction, Fibrinolysis (plasminogen activator release)

Conclusion

In conclusion, platelets are indispensable components of haemostasis, participating actively in all stages of the process. Their ability to adhere, activate, aggregate, and provide a surface for coagulation factors is crucial for effective wound healing and prevention of excessive blood loss. Dysregulation of platelet function can lead to bleeding disorders or thrombotic events, highlighting the importance of understanding their complex physiology. Further research into platelet biology continues to refine our understanding and improve therapeutic strategies for related conditions.

Answer Length

This is a comprehensive model answer for learning purposes and may exceed the word limit. In the exam, always adhere to the prescribed word count.

Additional Resources

Key Definitions

Thrombocytopenia
A condition characterized by a low platelet count, often leading to increased bleeding risk.
Von Willebrand Disease
A genetic disorder caused by a deficiency or dysfunction of von Willebrand factor, leading to impaired platelet adhesion and increased bleeding tendency.

Key Statistics

Approximately 3.9% of the US adult population has thrombocytopenia (based on 2018 data).

Source: National Heart, Lung, and Blood Institute (NHLBI)

Von Willebrand disease is the most common inherited bleeding disorder, affecting approximately 1% of the population.

Source: National Hemophilia Foundation (as of knowledge cutoff)

Examples

Hemophilia A and Platelet Dysfunction

Patients with Hemophilia A (Factor VIII deficiency) often experience prolonged bleeding, which can be exacerbated by even mild platelet dysfunction. Combined deficiencies pose a significant clinical challenge.

Frequently Asked Questions

What is the normal platelet count?

The normal platelet count ranges from 150,000 to 450,000 platelets per microliter of blood.

Topics Covered

PhysiologyHematologyBlood ClottingPlatelet FunctionHemostasis